Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website http://www.jocmr.org |
Original Article
Volume 3, Number 2, April 2011, pages 72-77
Risk Factors for Delayed Diagnosis of Scabies in Hospitalized Patients From Long-Term Care Facilities
Tables
SD = standard deviation | |
Age (years), mean ± SD | 80 ± 8.8 |
Gender (male : female) | 347 : 359 |
Duration from admission to diagnosis of scabies (days), mean (range) | 1 (0 - 12) |
Duration of hospitalization (days), mean (range) | 14 (1 - 388) |
Underlying disease | |
Chronic respiratory failure, n (%) | 288 (41) |
Congestive heart failure, n (%) | 96 (14) |
End stage renal disease, n (%) | 35 (5) |
Scabies infection before, n (%) | 360 (51) |
Cirrhosis, n (%) | 20 (3) |
Pressure sore, n (%) | 93 (13) |
Malignancy, n (%) | 45 (6) |
Diabetes mellitus, n (%) | 293 (42) |
Hypertension, n (%) | 567 (80) |
Bedridden status, n (%) | 610 (86) |
Steroid therapy, n (%) | 97 (14) |
Anti-parkinsonism agent therapy, n (%) | 103 (15) |
Anti-seizure therapy, n (%) | 186 (26) |
Bacteremia during hospitalization, n (%) | 225 (32) |
Laboratory data | |
White leukocyte (103/μL), mean ± SD | 13.3 ± 7.4 |
Eosinophil count (/μL), mean ± SD | 410 (0 - 43025) |
Hemoglobulin (g/dL), mean ± SD | 10.6 ± 2.0 |
Serum sodium (mmol/L), mean ± SD | 130.4 ± 9.1 |
Serum potassium (mmol/L), mean ± SD | 4.1 ± 0.9 |
Serum creatinine (mg/dL), mean ± SD | 1.3 ± 1.2 |
Serum urea nitrogen (mg/dL), mean ± SD | 26.4 ± 22.5 |
Serum albumin (g/dL), mean ± SD | 2.8 ± 0.7 |
Serum glutamic oxaloacetic transaminase (IU/L), mean (range) | 35.6 (6 - 1375) |
Variable | Delayed diagnosis (n = 44) | Early diagnosis (n = 662) | P value |
---|---|---|---|
SD = standard deviation*: P < 0.05 | |||
Age (years), mean ± SD | 78 ± 7.5 | 80 ± 8.9 | 0.223 |
Duration of hospitalization, days (range) | 30 (6 - 388) | 13 (1 - 221) | < 0.001* |
Male, n (%) | 27 (61) | 320 (48) | 0.129 |
Underlying disease | |||
Chronic respiratory failure, n (%) | 18 (41) | 270 (41) | 1.000 |
Congestive heart failure, n (%) | 4 (9) | 92 (14) | 0.501 |
End stage renal disease, n (%) | 4 (9) | 31 (5) | 0.266 |
Scabies infection before, n (%) | 19 (43) | 341 (52) | 0.360 |
Cirrhosis, n (%) | 0 (0) | 20 (3) | 0.629 |
Pressure sore, n (%) | 8 (18) | 85 (13) | 0.433 |
Malignancy, n (%) | 5 (11) | 40 (6) | 0.190 |
Diabetes mellitus, n (%) | 20 (45) | 273 (41) | 0.695 |
Hypertension, n (%) | 32 (73) | 535 (81) | 0.267 |
Bedridden status, n (%) | 41 (93) | 569 (86) | 0.259 |
Steroid therapy, n (%) | 32 (73) | 65 (10) | < 0.001* |
Anti-parkinsonism therapy, n (%) | 4 (9) | 99 (15) | 0.397 |
Anti-seizure therapy, n (%) | 13 (30) | 173 (26) | 0.748 |
Bacteremia, n (%) | 15 (34) | 210 (32) | 0.873 |
Laboratory data | |||
Leukocytosis, n (%) | 24 (55) | 378 (59) | 0.862 |
Eosinophilia, n (%) | 12 (27) | 116 (18) | 0.104 |
Anemia, n (%) | 22 (50) | 243 (37) | 0.109 |
Hyponatremia, n (%) | 28 (64) | 450 (68) | 0.647 |
Hypokalemia, n (%) | 11 (25) | 156 (24) | 0.982 |
Renal function impairment, n (%) | 10 (23) | 145 (22) | 1.000 |
Hypoalbuminemia, n (%) | 32 (73) | 454 (69) | 0.684 |
Liver function impairment, n (%) | 12 (27) | 181 (27) | 1.000 |
Variable | Odds ratio | 95% confidence interval | P value |
---|---|---|---|
Steroid therapy | 23.493 | 11.354 - 48.612 | < 0.001 |
Pathogens | No. of episodes |
---|---|
Coagulase-negative Staphylococci | 110 |
Staphylococcus aureus | 18 |
Unidentified gram-positive bacilli | 16 |
Streptococci | 3 |
Bacillus spp. | 2 |
Enterococci | 2 |
Acinetobacter spp. | 1 |